| Value | ₹2,007 Cr |
|---|
NSE filing, NSE: MBAPL. Summary written from the filing by ALFA Finder's alert engine.
Madhya Bharat Agro Products Ltd: key numbers
- Share price
- ₹174.00
- Market cap
- ₹7,984 Cr
- Revenue (annual)
- ₹1,867 Cr
- Net profit (annual)
- ₹150.2 Cr
- P/E (TTM)
- 51.5×Sector 9.7×
- Promoter holding
- 71.38%-3.38% QoQ
- FII holding
- 0.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Madhya Bharat Agro Products Ltd
All →Madhya Bharat Agro Products Credit Rating
CRISIL reaffirmed Madhya Bharat Agro's bank facility ratings at A+/Stable and Crisil A1 on October 7, 2026. Both ratings were removed from Rating Watch with Developing Implications.
Madhya Bharat Agro Products Production Started
Madhya Bharat Agro Products Limited has successfully commenced commercial production at its phosphoric acid plant in Dhule, Maharashtra. The facility has a capacity of 300 TPD.
- phosphoric acid production
- 300.0 TPD
Madhya Bharat Agro Products Capital Structure Change
MBAPL completed a preferential allotment of 20.72 lakh equity shares at ₹145 to 14 investors. The issuance raises ₹30.05 Crore, expanding paid-up capital to ₹91.77 Crore.
- Value
- ₹30.05 Cr
Madhya Bharat Agro Products Capital Structure Change
Madhya Bharat Agro Products allotted 2.07 crore shares at ₹145 in a preferential issue, raising ₹300.48 Crore. Post-allotment paid-up capital stands at 4.59 crore equity shares.
- Value
- ₹300.5 Cr
Madhya Bharat Agro Products Annual General Meeting
Madhya Bharat Agro Products Limited conducted an EGM on August 28, 2026. Shareholders approved a preferential equity issue to non-promoters and an amendment to the Company's Memorandum of Association.
Madhya Bharat Agro Products Annual General Meeting
Madhya Bharat Agro issued a corrigendum to its August 28, 2026 EGM notice, modifying the list of allottees for its proposed Rs 317.48 Crore preferential issue.
- Value
- ₹317.5 Cr
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.